VJHemOnc is committed to improving our service to you

ASH 2019 | Large B-cell lymphoma: relapsing post-axi-cel

VJHemOnc is committed to improving our service to you

Sattva Neelapu

Sattva Neelapu, MD, Anderson Cancer Center, Houston, TX, outlines an analysis of large B-cell lymphoma patients who relapsed post-axi-cel. The loss of CD19 due to the downregulation and alternating splicing of the gene is believed to be responsible for relapse after treatment with this CAR. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter